Success Metrics

Active Trials
3(100%)

Phase Distribution

Ph phase_2
1
33%
Ph phase_1
2
67%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 2Efficacy & side effects
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 12 (66.7%)
Phase 21 (33.3%)

Trials by Status

active_not_recruiting133%
recruiting267%

Recent Activity

3 active trials
Showing 3 of 3
recruitingphase_2

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

NCT07541287
recruitingphase_1

A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants

NCT07525947
active_not_recruitingphase_1

A Phase 1 Study of JADE101 in Healthy Participants

NCT07059312

Clinical Trials (3)

Showing 3 of 3 trials
NCT07541287Phase 2

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

Recruiting
NCT07525947Phase 1

A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants

Recruiting
NCT07059312Phase 1

A Phase 1 Study of JADE101 in Healthy Participants

Active Not Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3